Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REM (Risk Of Endometrial Malignancy): A Proposal for a New Scoring System to Evaluate Risk of Endometrial Malignancy

NCT01830192 is registered in ClinicalTrials.gov with Campus Bio-Medico University as lead sponsor.

NCT NCT01830192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01830192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REM (Risk Of Endometrial Malignancy): A Proposal for a New Scoring System to Evaluate Risk of Endometrial Malignancy
Lead sponsor
Campus Bio-Medico University
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2010
Completion date
December 31, 2012
Enrollment
741 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial disease